Trial Details
COMPLETEDBasic Information
| Clinical ID | c824 |
|---|---|
| Identifier | NCT05995899 |
| Trial Title | Effect of Tenapanor on the Metagenomics and Metabolomics of Patients With Irritable Bowel Syndrome With Constipation |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | IBS|IBS - Irritable Bowel Syndrome |
| Interventions | DRUG: Tenapanor |
Participant Information
| Sponsor | Kyle Staller, MD, MPH |
|---|---|
| City | Boston |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2024-02-06 |
|---|---|
| Primary Completion Date | 2025-12-17 |
| Completion Date | 2025-12-17 |